Stockreport

Travere Therapeutics Provides Corporate Update and 2026 Outlook

Travere Therapeutics, Inc.  (TVTX) 
PDF U.S. FILSPARI reaches all-time highs of 908 new PSFs and net product sales of approximately $103 million in 4Q 2025Company positioned for successful commercial launch of [Read more]